Losing weight can feel overwhelming, particularly when diet and exercise alone have not delivered the results you were hoping for despite genuine and sustained effort. Many people who struggle with their weight are not failing through lack of commitment or motivation. They are often managing a complex combination of biological, hormonal, metabolic, and lifestyle factors that make sustainable weight loss genuinely difficult without the right professional support.
At J E Williamson Pharmacy in Bishops Stortford, we offer a comprehensive range of weight loss services. These include personalised consultations, dietary and lifestyle guidance, and access to the most effective MHRA-licensed prescription weight loss treatments currently available in the UK. Whether you are new to medically supported weight loss or have tried other approaches without achieving lasting results, our clinical team is here to help.
Book a weight loss consultation at J E Williamson Pharmacy in Bishops Stortford today. Take the first step towards a personalised, clinically supported plan built around your health and your goals.
Key takeaways
- J E Williamson Pharmacy in Bishops Stortford offers a comprehensive weight management service including personalised consultations, dietary and lifestyle guidance, and access to the most effective MHRA-licensed prescription weight loss treatments currently available in the UK.
- Prescription weight loss treatment may be clinically appropriate for adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition such as type 2 diabetes, hypertension, or cardiovascular disease.
- Mounjaro (tirzepatide) is currently the most effective prescription weight loss treatment available in the UK, activating both GLP-1 and GIP receptors simultaneously to produce clinically meaningful average weight loss in patients with obesity.
- Weight loss treatment is available as a weekly injection or a daily oral tablet, with injectable options currently associated with the greatest average weight loss and oral options offering a needle-free alternative for patients who prefer not to inject.
- All prescription weight loss treatments provided through J E Williamson Pharmacy are preceded by a thorough clinical assessment and supported by ongoing monitoring, dietary guidance, and accessible professional support throughout treatment.
- Lasting weight loss always requires meaningful lifestyle change alongside any prescription treatment, and the dietary habits, physical activity, stress management, and behavioural changes developed during treatment are what protect results over the long term.
How Our Weight Loss Services Work
Our weight management service begins with a comprehensive one-to-one consultation with a member of our clinical team. This appointment is the foundation of everything that follows. During the consultation, your pharmacist will review your medical history and current health status. They will discuss your weight loss goals, the challenges you have faced, and the approaches you have already tried.
The consultation also explores the lifestyle, dietary, and behavioural factors most relevant to your individual circumstances. Where medical treatment is being considered, a thorough assessment of clinical suitability forms part of the evaluation. This includes a review of any existing health conditions, relevant medications, and any contraindications to treatment.
Following the consultation, a personalised plan is developed. This may include lifestyle guidance only, prescription treatment alongside lifestyle support, or a phased approach that evolves as your treatment progresses. Regular follow-up appointments are built into every programme we provide. These allow the clinical team to monitor progress, manage any side effects, and adjust recommendations as needed.
- A thorough review of your medical history and current health status
- A discussion of your goals, previous attempts, and the challenges you have faced
- Personalised advice on nutrition, physical activity, and behaviour change
- An assessment of whether prescription treatment is clinically appropriate
- A clear plan with realistic goals and regular follow-up to monitor progress
- Ongoing clinical support and accessible professional guidance throughout your journey
Who May Be Suitable for Weight Loss Treatment?
Pharmacy-led weight loss support can benefit a wide range of patients. The most commonly used clinical threshold for prescription weight loss treatment is a BMI of 30 or above. Treatment may also be appropriate for patients with a BMI of 27 or above when a weight-related health condition is present. These include type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease.
Prescription weight loss treatment is not appropriate for everyone. A thorough clinical assessment is always required before any treatment is initiated. Individual eligibility depends on a range of factors beyond BMI alone. These include overall health status, existing medications, medical history, and individual treatment goals.
If you have been struggling to lose weight despite genuine dietary and lifestyle effort, professional assessment may reveal specific factors that have been limiting your progress. These can often be addressed through a more targeted plan. Some patients benefit most from lifestyle-focused support alone. Others achieve significantly better outcomes with prescription treatment as part of a broader weight management programme.
- Adults with a BMI of 30 or above
- Adults with a BMI of 27 or above alongside a weight-related health condition
- Patients who have struggled to lose weight despite dietary and lifestyle changes
- Those with weight-related health conditions that would benefit from meaningful weight reduction
- Patients who want a structured, clinically supervised approach to weight management
- Those who have previously tried commercial programmes without achieving lasting results

Prescription Treatment vs Lifestyle Approaches
Weight loss can be approached through lifestyle changes alone, prescription treatment, or a combination of both. For many patients, a well-structured lifestyle approach is sufficient to achieve meaningful and sustainable weight loss. This is built around a consistent calorie deficit, adequate protein intake, increased physical activity, and behavioural change.
For others, particularly those with a significant amount of weight to lose or underlying conditions that make weight loss difficult, prescription treatment can make a substantial difference. The medications currently available in the UK, including Mounjaro and Wegovy, work by reducing appetite significantly. This makes it considerably easier to maintain the calorie deficit that drives weight loss, without the constant effort of resisting hunger that makes many dietary approaches difficult to sustain.
Prescription treatment is not a replacement for lifestyle change. The patients who achieve the best outcomes are those who combine the medication’s appetite-suppressing effects with active improvements to their dietary habits and physical activity levels. Our clinical team provides guidance on both throughout your treatment. A prescription without lifestyle support is a considerably less effective intervention than the two working together.
Not sure whether prescription treatment or a lifestyle-focused approach is right for you? The clinical team at J E Williamson Pharmacy in Bishops Stortford can help you make a fully informed decision. Contact us to book a consultation today.
Mounjaro (tirzepatide)
Mounjaro is currently the most effective prescription weight loss treatment available in the UK. It contains tirzepatide, a molecule that activates both GLP-1 and GIP receptors simultaneously. This dual mechanism produces a stronger effect on appetite regulation and metabolism than GLP-1 activation alone. It is associated with clinically meaningful average weight loss in patients with obesity, making it the most potent option currently in the class.
Mounjaro is administered as a once-weekly subcutaneous injection using the Mounjaro KwikPen. This is a pre-filled multi-dose device containing four once-weekly doses. A compatible needle must be attached before each injection and removed and safely disposed of afterwards. The medication is introduced through a gradual titration schedule. This begins at a low starting dose and increases over several weeks to minimise gastrointestinal side effects during the adjustment period.
The most commonly reported side effects of Mounjaro are gastrointestinal in nature. These include nausea, vomiting, diarrhoea, and constipation, and are typically most pronounced in the early weeks of treatment. They tend to improve as the body adjusts at each dose level. Mounjaro is not suitable for everyone and requires a thorough clinical assessment before it can be prescribed.
Call us to book a consultation and find out whether Mounjaro could be the treatment that finally delivers the results you have been working towards.
Wegovy (semaglutide)
Wegovy contains semaglutide at a dose specifically developed and MHRA-licensed for weight management in adults with obesity or overweight alongside weight-related health conditions. It works by activating GLP-1 receptors in the brain and gut to reduce appetite and slow gastric emptying. This produces a consistent and meaningful reduction in hunger and calorie intake that supports sustained weight loss over time.
Wegovy is also available as an oral tablet in addition to the established weekly injection. The injectable form uses the Wegovy FlexTouch pen, a pre-filled multi-dose device containing four once-weekly doses. Like Mounjaro, it requires a compatible disposable needle to be attached before each injection and removed and disposed of safely afterwards. The oral Wegovy tablet must be taken on an empty stomach with a small amount of water. It should be taken at least thirty minutes before food or other oral medications.
Wegovy has an established and well-characterised safety profile built on years of real-world clinical use in the UK and internationally. The STEP clinical trial programme demonstrated clinically significant average weight loss in participants with obesity. The SELECT cardiovascular outcomes trial also demonstrated a meaningful reduction in the relative risk of major cardiovascular events in patients with established cardiovascular disease. Like all GLP-1 treatments, the most commonly reported side effects are gastrointestinal in nature and are most pronounced during the titration phase.

Other Available Treatment Options
In addition to Mounjaro and Wegovy, a number of other weight loss treatments are available in the UK for eligible patients. Orlistat is a licensed oral weight loss medication that works by blocking the absorption of dietary fat in the gut rather than by suppressing appetite. It is available both on prescription and in a lower-dose over-the-counter formulation. It is most suitable for patients who wish to avoid injectable treatments and do not meet the clinical criteria for GLP-1 based options.
Foundayo (orforglipron) received MHRA authorisation in the UK on 10 August 2026 for weight management and type 2 diabetes. It is a once-daily oral GLP-1 receptor agonist that can be taken at any time of day without food or water restrictions. This makes it the most flexibly administered oral GLP-1 option currently available. Its average weight loss figures in clinical trials are somewhat lower than those for injectable GLP-1 treatments. It remains a genuinely meaningful option for patients who prefer a simple, restriction-free daily tablet.
The clinical team at J E Williamson Pharmacy in Bishops Stortford can advise on all available treatment options. They will help you identify the most clinically appropriate and practically sustainable choice for your circumstances.
The table below summarises all of the weight loss treatments currently available or recently authorised in the UK, covering how each is taken, any administration requirements, and its current regulatory status. Use it as a quick reference to compare your options before speaking to our clinical team.
| Treatment | Type | How taken | Administration requirements | UK status |
|---|---|---|---|---|
| Mounjaro (tirzepatide) | GLP-1 and GIP receptor agonist | Weekly injection | No food or water restrictions | MHRA-licensed; available now |
| Wegovy injection (semaglutide) | GLP-1 receptor agonist | Weekly injection | No food or water restrictions | MHRA-licensed; available now |
| Wegovy pill (oral semaglutide) | GLP-1 receptor agonist | Daily tablet | Empty stomach; small amount of water; 30 minutes before food | MHRA approved June 2026; availability developing |
| Foundayo (orforglipron) | GLP-1 receptor agonist (small molecule) | Daily tablet | No food or water restrictions; any time of day | MHRA authorised 10 August 2026; commercial availability developing |
| Orlistat | Lipase inhibitor | Three times daily tablet | Taken with each main meal containing fat | MHRA-licensed; available on prescription and over the counter |
Injections vs Oral Treatments
The choice between injectable and oral weight loss treatment is one of the most significant practical decisions any patient beginning a weight management programme will make. Injectable treatments, including Mounjaro and injectable Wegovy, are administered once weekly. They have the most extensive clinical trial evidence and are associated with the greatest average weight loss outcomes currently achievable with any licensed medication in the UK. For patients who are comfortable with self-injection, they are the most powerful available option.
Oral treatments, including the Wegovy pill and Foundayo, offer a needle-free alternative that many patients find more accessible and easier to integrate into daily life. The Wegovy pill requires administration on an empty stomach with a small amount of water, at least thirty minutes before food or other oral medications. Foundayo can be taken at any time of day without food or water restrictions. Both oral options produce clinically meaningful weight loss, though average figures from clinical trials are somewhat lower than those associated with injectable treatments.
Needle anxiety is a common and entirely understandable reason for preferring an oral treatment. It is also worth noting that the Mounjaro KwikPen and Wegovy FlexTouch are both designed to make self-injection as straightforward as possible. The vast majority of patients who are apprehensive before their first injection report that the experience is considerably simpler and more comfortable than they anticipated. A supervised first injection with a member of our clinical team can provide significant reassurance for patients who are concerned about this aspect of treatment.
NHS vs Private Access
Both Mounjaro and Wegovy are available on the NHS. However, NHS access is currently subject to strict eligibility criteria and limited rollout through specialist weight management services. There is also significant variation in availability between different areas of England. NHS provision is primarily delivered through tier 3 and tier 4 weight management services and is not yet widely available through GP practices for the weight management indication. Waiting times for NHS-commissioned services can be lengthy in many areas.
Private access through a registered, regulated pharmacy such as J E Williamson Pharmacy in Bishops Stortford allows eligible patients to begin treatment without waiting for an NHS referral. Private prescribing requires the same standard of clinical assessment as NHS prescribing. A thorough consultation confirming suitability for treatment is required before any prescription can be issued. The key practical differences are speed of access and cost, rather than clinical standards or the quality of the medication supplied.
Patients who are interested in NHS access are encouraged to speak to their GP about referral pathways available in their area. For those who wish to begin treatment sooner, a private consultation at J E Williamson Pharmacy in Bishops Stortford provides a clinically safe, properly regulated route to access. This also applies to patients who do not currently meet NHS commissioning criteria.
Safety and Medical Assessment
The safety of any weight loss treatment begins with the quality of the clinical assessment that precedes it. No prescription weight loss medication is provided at J E Williamson Pharmacy without a thorough evaluation of individual suitability. This assessment considers BMI, health history, existing medications, relevant contraindications, and the patient’s understanding of the treatment, its expected effects, and its potential side effects.
Patients are also supported throughout treatment with regular monitoring and accessible professional guidance. This is particularly important during the early weeks of treatment, when gastrointestinal side effects are most commonly reported and when patients may have questions about what they are experiencing. Prompt access to clinical support at this stage makes a meaningful difference to both treatment adherence and patient safety.
All weight loss medications supplied through J E Williamson Pharmacy are obtained from licensed UK pharmaceutical suppliers. They are the same regulated products available through NHS and other regulated private services. Patients should always access weight loss treatment through a GPhC-registered pharmacy with a properly regulated prescribing process. Obtaining prescription weight loss medication from unregulated online sources carries serious and direct safety risks, and the MHRA has consistently warned against this practice. Any suspected counterfeit medicines should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.
Costs
The cost of private weight loss treatment varies depending on the specific medication, the dose, and the level of clinical support included in the programme. As a general indication, injectable GLP-1 treatments such as Mounjaro and Wegovy are priced monthly and vary in cost depending on dose strength. Oral options such as the Wegovy pill and Foundayo are priced per monthly supply. Orlistat is considerably less expensive and is available at a lower cost both on prescription and over the counter.
It is important to factor the cost of clinical support into any comparison of treatment prices. A lower-cost prescription from an online provider with minimal clinical assessment and no ongoing monitoring is not equivalent to a properly supported treatment programme. A properly supported programme includes regular follow-up, dietary guidance, side effect management, and accessible professional support throughout. The clinical support provided alongside the medication is one of the most important determinants of treatment outcomes.
For specific pricing information for the treatments and programmes available at J E Williamson Pharmacy in Bishops Stortford, please contact our team directly. Pricing is reviewed regularly and our team can provide current costs and help you understand what is included in each programme before you commit to treatment.
The cost of treatment makes most sense when it is weighed against the results it could realistically produce for you personally. Try our calculator below and enter your height and weight to see how much you could potentially lose with Mounjaro or Wegovy:
Diet, Exercise, and Long-Term Maintenance
Prescription weight loss medication is most effective when used within a comprehensive weight management approach that includes active dietary and lifestyle changes. Clinical trial participants in the STEP and SURMOUNT programmes received dietary counselling and support alongside their medication. The average weight loss figures from these trials reflect this combination rather than the medication alone.
From a dietary perspective, the most impactful changes for patients on weight loss medication are prioritising protein-rich foods to preserve muscle mass and extend satiety. Increasing fibre intake through vegetables, legumes, and wholegrains is equally important. Reducing ultra-processed foods and calorie-containing beverages, and building a consistent calorie balance without extreme restriction, completes the dietary foundation. Physical activity supports weight loss through increased calorie expenditure and also protects muscle mass, improves metabolic rate, and supports sleep quality, mood, and stress management.
Long-term maintenance of weight loss following the completion or reduction of prescription treatment requires the habits developed during treatment to be genuinely embedded in daily life. The clinical evidence consistently shows that weight regain is common after stopping GLP-1 medications if lifestyle habits have not been meaningfully changed alongside treatment. This is why our service includes practical, ongoing dietary and lifestyle support throughout the entire treatment period, not just at the initial consultation.
- Prioritise protein-rich foods at every meal to support muscle preservation and satiety
- Increase fibre intake through vegetables, legumes, wholegrains, and fruit
- Reduce ultra-processed foods and calorie-containing beverages throughout treatment
- Build consistent physical activity into your routine to support metabolic rate and body composition
- Focus on embedding habits that can be maintained after treatment concludes
- Seek regular clinical review to ensure your plan evolves as your treatment and circumstances change
Frequently Asked Questions
Here are the weight loss questions the clinical team at J E Williamson Pharmacy in Bishops Stortford is asked most frequently by patients at every stage of their treatment journey.
Start Your Weight Loss Journey Today
At J E Williamson Pharmacy in Bishops Stortford, our goal is to help every patient feel healthier, more confident, and genuinely well-supported. We offer the full range of MHRA-licensed weight loss treatments, expert clinical assessment, and personalised dietary guidance. We also provide the kind of ongoing professional support that makes a genuine and measurable difference to outcomes. Whether you are exploring your options for the first time or have been working towards a long-standing goal, our expert clinical team is here to help.
Book a consultation and begin your weight loss journey with the right treatments, the right team, and the right support in place from the very first appointment.

Disclaimer: The information on this page is intended for general informational purposes only and does not constitute medical advice. Weight loss treatments including Mounjaro, Wegovy, Foundayo, and Orlistat are prescription-only or regulated medications that require a thorough clinical assessment before use. Always speak to a qualified medical professional before starting, changing, or stopping any weight management treatment. Individual results and suitability for treatment will vary.
